Group Chief Medical Officer

International Permanent CA$614,447 - CA$750,991 per year View Job Description
This Global Chief Medical Officer, the most senior medical leader for the company, setting the overall clinical and medical strategy across the group.

This role uses AI-assisted tools to support initial screening. All assessments and decisions are made by a human reviewer.

  • Group Chief Medical Officer cross mutiple therapeutic area globally.
  • AI driven antibody drug development platform

About Our Client

This is a listed, AI driven antibody drug development platform, cross muitlple therapeutic areas. This biopharma company provides operation sites in USA, China and Europe.

Job Description

Key Responsibilities:

  • Set group-wide clinical development strategy across the four TAs (Oncology, Immunology, Obesity/Metabolic, Neuroscience), including prioritization and go/no-go.
  • Provide clinical/medical governance and standards across HM and NewCos; coordinate resources and avoid duplication.
  • Oversee global registration strategy, China (NMPA) + US (FDA) dual filing and multi-regional trials.
  • Support group BD (shift to in-licensing): medical due diligence and value judgment on assets.
  • Partner with RA (regulatory), KOLs and health authorities; represent HBM's medical voice externally.
  • Build and develop clinical/medical leadership and matrix teams across entities.



MPI does not discriminate on the basis of race, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, or based on an individual's status in any group or class otherwise protected under applicable human rights legislation. MPI encourages applications from minorities, women, the disabled and all other qualified applicants

The Successful Applicant

Key Requirements:

  • PhD, MD, Mutinational Corporate and biotech blended background, brings big-pharma global rigor and biotech agility to the team
  • Strong reputation and stability; China / US / cross-border experience; base both in China and USA
  • Broad, cross-therapeutic area clinical development expertise (Ph1-Ph3, IND/BLA/NDA); comfortable across multiple therapeutic areas, not a single-TA specialist.
  • Experience with complex biologics/large molecules (antibodies, bispecifics/multispecifics, TCE, ADC), aligned with HBM's core modalities.
  • Global registration experience, China + US dual filing, multi-regional / MNC collaboration (e.g., AZ, BMS).
  • Group / multi-product / multi-TA CMO or senior clinical leadership experience (not single-product CMO).
  • Strategic and matrix leadership, ability to steer and align franchises with gravitas; cross-functional (R&D/RA/BD/CMC/Commercial).

MPI does not discriminate on the basis of race, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, or based on an individual's status in any group or class otherwise protected under applicable human rights legislation. MPI encourages applications from minorities, women, the disabled and all other qualified applicants.

What's on Offer

  • Competitive annual salary ranging from $450000 to $550000 USD.
  • Permanent position within the life sciences industry.
  • Location in Shanghai offering a varied and diverse environment.
  • Additional benefits to be discussed during the hiring process.



If this role aligns with your experience, we encourage you to apply.

Contact
Annie Shen
Quote job ref
JN-092026-7094751

Job summary

Sector
Engineering & Manufacturing
Sub Sector
General Management
Industry
Healthcare / Pharmaceutical
Where
International
Job Type:
Permanent
Consultant name
Annie Shen
Job Reference
JN-092026-7094751